Michael Kauffman, Director at Karyopharm Therapeutics Inc. (KPTI), sold 12,452 shares at $10.24 ($128K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
Open-market sale of $128k KPTI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.24 | 6,226 | $64K | 50.0% |
| 2 | $10.24 | 6,226 | $64K | 50.0% |
| Total | $10.24 avg | 12,452 | $128K | 100% |
| Filing → |
| KPTI | SELL | 2022-02-22 | $440K | — | Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |
| KZR | SELL | 2022-01-05 | $82K | — | Filing → |